Llwytho...
What do oncologists need to know about biosimilar products?
Many biologic products have improved the outcomes of cancer patients, but the costs can substantially burden healthcare systems. Biosimilar products can potentially reduce drug costs and increase patient access to beneficial treatments. Approval of a biosimilar product relies on the demonstration of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Chin J Cancer |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5062853/ https://ncbi.nlm.nih.gov/pubmed/27733189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0151-x |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|